Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients
Patricia Rojas-Pérez-Ezquerra, Jimena Crespo Quirós, Pampa Molina, María Luisa Baeza Ochoa de Ocáriz, JM Zubeldia Ortuño
Abstract
Table 1.Referral questionnaire for controlled administration of mRNA vaccines against COVID-19 in the Allergy DepartmentHave you ever had a serious allergic reaction (anaphylaxis): sudden onset of shortness of breath, feeling of difficulty swallowing, dizziness, or loss of consciousness, swelling of the face, lips, or uvula, with the administration of: food, medicine, latex, previous vaccinations, wasp/bee sting or no known cause?Have you been diagnosed with mastocytosis or mast cell activation syndrome?Have you been diagnosed with allergy to PEG = polyethylene glycol = macrogol?Have you been diagnosed with allergy to polysorbate?Have you been diagnosed with severe asthma?Have you been diagnosed with chronic urticaria / angioedema?